Highlights:
- Total Operating Revenue of $111.300 million in FY14, an increase of 17% over the prior corresponding period (pcp)
- Net Profit After Tax of $10,000 significantly impacted by an adverse movement in the NZD/AUD exchange rate compared to the pcp
- Strong balance sheet with $16m cash on hand and no debt
- Increased market share in Australia with fresh milk sales up 24% over the pcp
- Modest sales of a2Platinum® infant formula into China due to regulatory issues
- Successful launch of a2Platinum® infant formula in Australia
- New UK business structure from January 2014
- World’s first human pilot study recently released confirms A2 beta casein protein digestive benefit
To view the full year 2014 announcement, please click here
For announcement supporting documentation, please click here
To read the FY 2014 results presentation, please click here
